Table 1.
Patients’ characteristics
| Characteristics | n | (%) | |
|---|---|---|---|
| Age (y) | Median (range) | 63 | (range, 27–81) |
| Sex | Male | 137 | (87%) |
| Female | 20 | (13%) | |
| Performance | ECOG 0 | 39 | (25%) |
| ECOG 1 | 111 | (71%) | |
| ECOG 2 | 7 | (4%) | |
| Histology | Squamous cell carcinoma | 86 | (55%) |
| Adenocarcinoma | 52 | (33%) | |
| Large cell carcinoma | 2 | (1%) | |
| NSCLC, NOS | 17 | (11%) | |
| T stage | 1 | 18 | (11%) |
| 2 | 61 | (39%) | |
| 3 | 34 | (22%) | |
| 4 | 44 | (28%) | |
| N stage | 0 | 3 | (2%) |
| 1 | 3 | (2%) | |
| 2 | 75 | (48%) | |
| 3 | 76 | (48%) | |
| Stage | IIIA | 49 | (31%) |
| IIIB | 108 | (69%) | |
Abbreviations: ECOG Eastern Cooperative Oncology Group, NSCLC Non-small-cell lung cancer, NOS Not otherwise specified.